MeSH D008206 - lymphatic diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008206:
Lymphatic diseases
0 Companies
0 Drugs
Success rate
D000072281:Lymphadenopathy
0 Companies
0 Drugs
Success rate
D008199:Lymphadenitis
0 Companies
0 Drugs
Success rate
D008200:Lymphangiectasis
0 Companies
0 Drugs
Success rate
D008205:Lymphangitis
0 Companies
0 Drugs
Success rate
D008209:Lymphedema
0 Companies
0 Drugs
Success rate
D008210:Lymphocele
0 Companies
0 Drugs
Success rate
D008232:Lymphoproliferative disorders
D009080:Mucocutaneous lymph node syndrome
D013952:Thymus hyperplasia
0 Companies
0 Drugs
Success rate
D013953:Thymus neoplasms
0 Companies
0 Drugs
Success rate
D015614:Histiocytosis
D019310:Pseudolymphoma
0 Companies
0 Drugs
Success rate
D044148:Lymphatic abnormalities
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
20%1/5
Phase 2
0%0/5
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use